Prof Nancy Devlin
LightNews LightNews
banner
prof-nancy-devlin.bsky.social
Prof Nancy Devlin
@prof-nancy-devlin.bsky.social
1K followers 610 following 110 posts
Editor in Chief at Value in Health, Board chair at EuroQol Research Foundation, Rotterdam & Professor of Health Economics at University of Melbourne. Proud mum of three wonderful adults and grandma to two very energetic tiny humans.
Posts Replies Media Videos
Reposted by Prof Nancy Devlin
euroqol.bsky.social
EQ-TIPS was developed to meet growing interest in evaluating the effectiveness & cost-effectiveness of treatments in very young children 👶

In this paper, @prof-nancy-devlin.bsky.social et al. examine issues in valuing the EQ-TIPS and possible adaptations to valuation methods 👉 bit.ly/4oxl4gF
Text: ‘Publication, Paper Tuesday - Valuing health states for infants and toddlers: challenges and methodological considerations in EQ-TIPS preferences elicitation. by Devlin, N. et al. (2025).' The background is a gradient blue with overlaid images of books and the world map.
August 19, 2025 at 12:19 PM
prof-nancy-devlin.bsky.social
New paper: "Measuring & Valuing Health Using EuroQol Instruments: New Developments 2025 and Beyond"

▶️open access: tinyurl.com/EuroQol2025u...

@fengtastic.bsky.social @beaunebeaune.bsky.social @ellystolk.bsky.social

#HealthEconomics #PROMS #HRQOL #EQ-5D #EQ-5D-Y #EQ-HWB-9 #EQ-TIPS #Bolt-ons
Highlight points from a new paper summarising established and new tools for measuring and valuing health related quality of life, developed by a not for profit organisation called the EuroQol Research Foundation.
July 27, 2025 at 10:15 PM
prof-nancy-devlin.bsky.social
Thanks @frasermorton.bsky.social for adding the Australian value set for the EQ-5D-Y-3L to your #rstats #EQ5D package! That was quick work!

@euroqol.bsky.social @rich-norman.bsky.social
Our paper is available here, open access:
➡️https://tinyurl.com/AussieY-3Lvalueset
July 23, 2025 at 6:52 PM
prof-nancy-devlin.bsky.social
I'm looking forward to the 2025 #iHEA Congress, & the pre-congress @euroqol.bsky.social session.

Authors: If you're presenting a paper at iHEA & thinking of submitting it to #ValueinHealth - drop me a message! I'll do my best to come to your session. Or just come up & say hi!

#healtheconomics #VIH
July 12, 2025 at 3:06 AM
prof-nancy-devlin.bsky.social
Will Trump's plan to use 'Reference Pricing' cut US drug prices? This #ValueinHealth paper by Grueger, Martin & Sullivan argues reference pricing is ill-advised & will lead to unintended consequences.

open access 👉 tinyurl.com/reference-pr...

#Trump #HealthEconomics
Image is copyright to Jane Doe/ Shutterstock. Shows a cartoon image of Donald Trump with a signed Executive Order
July 11, 2025 at 4:16 AM
prof-nancy-devlin.bsky.social
News from the English NHS: www.bbc.com/news/article...

#genomics #precisionmedicine
@eigen-uom.bsky.social
NHS plans to DNA test all babies in England to assess disease risk
Scheme is part of the government's 10-year plan for the NHS in England aimed at easing pressure on services.
www.bbc.com
June 22, 2025 at 4:02 AM
prof-nancy-devlin.bsky.social
New impact factor for Value in Health. We're chuffed!
#healtheconomics
just a big yellow-coloured number 6.0
June 22, 2025 at 1:02 AM
prof-nancy-devlin.bsky.social
This letter, in the June issue of Value in Health, makes for pretty interesting reading:
www.valueinhealthjournal.com/article/S109...

#healtheconomics #equity #HTA
Why Is Distributional Cost-Effectiveness Analysis Not Ready for Prime Time in Health Technology Assessment?
The systematic review by Merga et al1 examining economic evaluations that address inequalities in cancer care had a striking result in that only 13% of studies identified used distributional cost-effe...
www.valueinhealthjournal.com
June 22, 2025 at 12:23 AM
prof-nancy-devlin.bsky.social
New Value in Health paper, "Drop the M", of interest to anyone struggling with how to interpret data from patient reported outcome measures, and what a Minimally Important Difference means. Authors: Vickers, Nolla & Cella.
👉 pubmed.ncbi.nlm.nih.gov/40216310/

#HealthEconomics
Drop the "M": Minimally Important Difference and Change Are Not Independent Properties of an Instrument and Cannot Be Determined as a Single Value Using Statistical Methods - PubMed
MID must be estimated within a specific study context. It is best to think of PRO measures in terms of "ID" and leave the "M" to case-by-case, context-based interpretation.
pubmed.ncbi.nlm.nih.gov
June 22, 2025 at 12:16 AM
prof-nancy-devlin.bsky.social
Hey @altmetric.com, I was wondering if you've got any updates on this you could share? #AcadmicSky #EconSky
June 15, 2025 at 12:26 AM
Reposted by Prof Nancy Devlin
davidedmonds100.bsky.social
Two great philosophers retiring. Two conferences to honour them. Two great line ups. Both open to the public. Sign up.
Jo Wolff www.bsg.ox.ac.uk/events/publi...
& Jeff McMahan
www.ccc.ox.ac.uk/alumni/event...
The Public Philosopher
Join us for a day of philosophical discussion in honour of Professor Jo Wolff's career.
www.bsg.ox.ac.uk
May 6, 2025 at 3:13 PM
prof-nancy-devlin.bsky.social
Tomorrow at #ISPOR2025: in this 75-min 'spotlight' session we will give in-depth consideration of whether Cost Benefit Analysis could play a bigger role in HTA. If you are here in Montreal, I hope to see you there!
#HealthEconomics
A powerpoint slide from Prof. Devlin linking the case for CBA to the need for cross-sectoral economic evaluation
May 16, 2025 at 1:56 AM
prof-nancy-devlin.bsky.social
An update on NICE methods regarding health inequalities in health technology evaluations is out now:

tinyurl.com/NICEmethodsh...

#HealthEconomics
Health inequalities - an update to NICE’s methods for health technology evaluation
www.nice.org.uk
May 16, 2025 at 1:34 AM
prof-nancy-devlin.bsky.social
@euroqol.bsky.social puts out these useful posts regularly, where they do a quick ‘round-up ’ of new papers published about EQ-5D and related instruments. I find therir posts very helpful. If you’re interested in HRQoL, utilities etc, it’s worth following them!
#HealthEconomics #PROMs
euroqol.bsky.social EuroQol Research Foundation @euroqol.bsky.social · May 14
Brand new selection of scientific papers on EuroQol instruments listed below - check them all out! 📚

1/
May 14, 2025 at 7:17 PM
prof-nancy-devlin.bsky.social
#ISPORAnnual Virginia Acha notes that tough pricing regulation in the US will reduce incentives for investment in innovation - and this is a double whammy if coupled with reduced US funding of basic science.
#referencepricing #HealthEconomics
May 14, 2025 at 1:49 PM
prof-nancy-devlin.bsky.social
At ISPOR 2025 Darius Lakdawalla: some form of price intervention is now inevitable in the US, hopefully based on value, and done in a ‘US specific way’. Time for the US to adopt its own HTA.
May 14, 2025 at 1:34 PM
prof-nancy-devlin.bsky.social
At today’s ISPOR conference: Sean Sullivan arguing US reference pricing is ‘lazy and misguided’ - but has bipartisan support.
May 14, 2025 at 1:27 PM
prof-nancy-devlin.bsky.social
I'm guessing this is going to be a hot topic of conversation here at ISPOR Montreal over the coming days!
www.theguardian.com/business/202...
#HealthEconomics
Drug price cuts: what is Trump planning and what will it mean for big pharma?
President has directed Robert Kennedy to send price targets to industry, with slimming drugs thought to be included
www.theguardian.com
May 13, 2025 at 2:37 PM
prof-nancy-devlin.bsky.social
Will the US introduce 'reference pricing'?
www.reuters.com/business/hea...
Trump to sign executive order on reducing prescription drug prices
U.S. President Donald Trump said on Sunday he would sign an executive order that he said would reduce prescription drug and pharmaceutical prices by between 30% and 80%.
www.reuters.com
May 12, 2025 at 1:58 PM
prof-nancy-devlin.bsky.social
[1/2] "24 yrs After the Launch of the EU Orphan Regulation: Analyzing Dutch Price Dynamics, Biosimilars & Generics for Orphan Medicinal Products"by Sibren van den Berg & colleagues in the May issue of Value in Health @amsterdamumc.bsky.social

👉 tinyurl.com/EUOrphanMeds
#HealthEconomics
abstract of a new paper just published in Value in Health, May 2025, Twenty-Four Years After the Launch of the EU Orphan Regulation: Analyzing Dutch Price Dynamics, Biosimilars, and Generics for Orphan Medicinal Products
May 12, 2025 at 4:36 AM
prof-nancy-devlin.bsky.social
"The Price Effects of Biosimilars In the US" by Mireia Jofre-Bonet et al. concludes the US biosimilars market has become highly competitive; driving price reductions between 2015-2023 with substantial savings for Medicare

➡️ tinyurl.com/PriceEffects...

@ohenews.bsky.social
#HealthEconomics
abstract of a new paper in Value in Health, May 2025, by Mireia Jofre-Bonet and colleagues about the effect of biosimilars on prices in the US
May 12, 2025 at 4:06 AM
prof-nancy-devlin.bsky.social
Are women under-represented in publishing in #HealthEconomics? We did an analysis of submissions and acceptances to Value in Health. Results are quite encouraging - but still scope for improvement.

open access paper here: tinyurl.com/WomenAuthors...
highlight points from a paper published in Value in Health, looking at how well women are represented in authorship of papers submitted and accepted by the journal.
May 7, 2025 at 11:46 PM
prof-nancy-devlin.bsky.social
What is 'Whole Health' and what does it mean for approaches to economic evaluation? The new issue of Value in Health has articles on this from US CDC, WHO & ISPOR, and this little editorial from me & fellow editors Daniel Mullins & Pieter van Baal:

👉 tinyurl.com/WhatDoesWhol...

#HealthEconomics
screenshot of an editorial in the May 2025 issue of Value in Health. The paper discussed what the term 'Whole Health' means and discuses some of the implications for how we evaluate costs and benefits.
May 7, 2025 at 10:58 PM
prof-nancy-devlin.bsky.social
I love it when someone really interesting is interviewed on the news sitting in front of their bookcase. @maryrziegler.bsky.social's new book, 'Personhood: The New Civil War Over Reproduction' now added to my reading list. @cnn.com
Photo of author and researcher Mary Ziegler being interviewed on CNN about her new book, 'Personhood: the new civil war over reproduction'.
April 29, 2025 at 5:52 AM
prof-nancy-devlin.bsky.social
When QALYs, VAS and standard gamble make it onto TV...
tinyurl.com/38xvf8vy
#universitychallenge | Chloë Hardern | 16 comments
Health economics spotted in the wild… did anyone else get 100%? 💅 #universitychallenge | 16 comments on LinkedIn
www.linkedin.com
April 27, 2025 at 1:00 AM